MedImmune Keeps Up Fight Against Generic Ethyol

Law360, New York (February 25, 2009, 12:00 AM EST) -- MedImmune LLC has sued Sun Pharmaceutical Industries Ltd. and Caraco Pharmaceutical Laboratories Ltd. again for allegedly infringing two patents related to the cancer therapy drug Ethyol, which Sun and Caraco have been selling in generic form since March.

MedImmune lodged the suit against Caraco and Sun, Caraco's majority shareholder, on Tuesday in the U.S. District Court for the District of Maryland, where related litigation over the same patents has been pending since 2004.

MedImmune said it filed a new complaint against Sun and Caraco in order...
To view the full article, register now.